P099 The London CTAP network standard operating procedure for averting medications prohibited during clinical trials in cystic fibrosis.

Autor: Le Sayec, M.1 (AUTHOR), Davies, G.2,3 (AUTHOR), Waller, M.D.1,4 (AUTHOR), Davies, J.C.5,6 (AUTHOR), Simmonds, N.J.5,6 (AUTHOR), Jones, A.5 (AUTHOR), Brugha, R.2,3 (AUTHOR), Dawson, C.3 (AUTHOR), Macedo, P.1 (AUTHOR), Ruiz, G.1 (AUTHOR), Hughes, D.1 (AUTHOR), Pao, C.7 (AUTHOR), Shafi, N.7 (AUTHOR), Brown, S.7 (AUTHOR), Watson, D.7 (AUTHOR), Baker, L.8 (AUTHOR), Lillis, A.9 (AUTHOR), Ruffles, T.10 (AUTHOR), Rajkov-Mazowiecki, M.5 (AUTHOR), Needham, Y.5 (AUTHOR)
Zdroj: Journal of Cystic Fibrosis. 2024 Supplement 1, Vol. 23, pS97-S98. 2p.
Databáze: Academic Search Ultimate
Externí odkaz: